DIARY-Germany corporate earnings week ahead Aug 30 (Reuters) - Diary of Germany (.GDAXI) corporate earnings for the week ahead GERMANY EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 02-Sep-2024 09:00 BAYGn.DE Bayer AG Bayer AG Investor Webinar to Discuss Results from FINEARTS-HFP ** All times are listed in AMC - 'After market close', or BMO - 'Before market opens', or DBH - 'During business hours', or NTS - 'No time scheduled' ** This Diary does not provide the EPS estimate fig

DIARY-Europe's STOXX 600 corporate earnings week ahead Aug 30 (Reuters) - Diary of Europe's STOXX 600 (.STOXX) corporate earnings for the week ahead EUROPE'S STOXX 600 EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 02-Sep-2024 09:00 BAYGn.DE Bayer AG Bayer AG Investor Webinar to Discuss Results from FINEARTS-HFP 02-Sep-2024 09:00 PZU.WA Powszechny Zaklad Ubezpieczen SA Half Year 2024 Powszechny Zaklad Ubezpieczen SA Investor Chat (Polish) 03-Sep-2024 NTS BKWB.S BKW AG Half Year

FACTBOX-European companies cut jobs as economy sputters Adds Shell Aug 30 (Reuters) - Elevated levels of inflation and the impact of the war in Ukraine have forced companies across Europe to freeze hiring or cut jobs. Here are some of the layoffs announced since the start of April: BANKS * TSB: The British bank owned by Spain's Sabadell SABE.MC is seeking 250 job cuts, its spokesperson and employee union said on May 8. INDUSTRIALS AND ENGINEERING * PKP CARGO PKPP.WA : Poland's largest freight co

BRIEF-Bayer Starts Late Stage Trial In Lung Cancer Therapy Aug 29 (Reuters) - Bayer AG BAYGn.DE : STARTS PHASE III TRIAL IN NON-SMALL CELL LUNG CANCER (NSCLC) FIRST PATIENT ENROLLED IN PHASE III SOHO-02 TRIAL OF INVESTIGATIONAL AGENT BAY 2927088 IN TREATMENT-NAÏVE PATIENTS WITH ADVANCED NSCLC WITH HER2-ACTIVATING MUTATIONS DATA FROM PHASE I/II SOH

UPDATE 1-ADNOC finalising due diligence on Covestro, sources say Adds details, background in paragraphs 4-8 By Emma-Victoria Farr FRANKFURT, Aug 28 (Reuters) - Abu Dhabi National Oil Company (ADNOC) is finalising due diligence for a takeover of Covestro 1COV.DE in a deal that could reach 11.7 billion euros ($13 billion), two sources familiar with the matter told Reuters on Wednesday.